HSA — authorised 15 May 2013
- Marketing authorisation holder: BAYER HLTHCARE
- Status: likely_approved
🇸🇬 Xofigo in Singapore
HSA authorised Xofigo on 15 May 2013
Marketing authorisation
Xofigo in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in Singapore
Frequently asked questions
Is Xofigo approved in Singapore?
Yes. HSA authorised it on 15 May 2013.
Who is the marketing authorisation holder for Xofigo in Singapore?
BAYER HLTHCARE holds the Singaporean marketing authorisation.